Bairbre McNicholas and Jie Li discuss an open label superiority meta-trial looking at the efficacy of awake prone positioning for patients with COVID-19 acute hypoxaemic respiratory failure.   

Charles Sprung and fellow co authors Christiane Hartog, Joseph Nates, and Gavin Joynt discuss the Ethicus-II study, which looked at differences in end-of-life care in nearly 200 ICUs across 36 countries.

Christopher Brightling discusses the effect of blocking thymic stromal lymphopoietin (TSLP) with tezepelumab in patients with moderate-to-severe uncontrolled asthma.

Dr. Paul Verweij discusses a Personal View published in TLRM on COVID-19 associated aspergillosis.

Dr. Ignacio Rubio discusses a comprehensive review of the pathophysiology and phenotypes of COVID-19, the first in a Series of four papers about the pathophysiology of acute disease.

Dr. Kiran Shekar discusses a randomized controlled trial looking at cytokine adsorption in patients with severe COVID-19 pneumonia.

Dr Fan Chung discuses confronting COVID-19-associated cough and the post-COVID syndrome

Dr. Joseph Han discusses the results of the phase III SYNAPSE trial, evaluating the efficacy and safety of mepolizumab in patients with chronic rhinosinusitis

Dr. Mona Bafadhel discusses the STOIC trial, which looked at the use of inhaled budesonide in the treatment of early COVID-19.

Dr. Arvinder Soin discusses the use of tocilizumab plus standard care versus standard care alone in the treatment of moderate to severe COVID-19-associated cytokine release syndrome. 

Jordan Feld discusses the use of peginterferon-lambda in the treatment of ambulatory COVID-19 patients.

Rishi Gupta discusses a model to evaluate and predict the risk of clinical deterioration in patients with acute COVID-19

Toby Maher discusses the results of the SENSCIS trial, looking at the safety and efficacy of nintedanib in systemic sclerosis-associated interstitial lung disease (SSc-ILD) treated with mycophenolate.

Dr. Catherine Quantin discusses a new study looking at the ways severe influenza and COVID-19 are similar and differ. 

Dan Lewer of University College London discusses a modelling study that looks at housing strategies for homeless populations in the UK during COVID-19.

Richard Beasley discusses a Series of three papers in The Lancet and The Lancet Respiratory Medicine that consider the promise of novel strategies to drive down the global burden of asthma.

Dr. Reagan-Steiner and Dr. Gary about pathlogical findings in suspected cases of e-cigarette, or vaping, product use-associated lung injury, or EVALI.

Dr. Tina Hartert discusses a new study that aimed to evaluate the strength for a causal effect of Respiratory Syncytial Virus-Lower Respiratory Tract Infection (RSV-LRTI) in subsequent chronic wheezing illness to inform public health expectations for...

Authors of a new population-based study on the association between antibiotic use in infancy and risk of asthma later in life discuss the results of their trial and how they might influence paediatricians and parents.

David Maslove and Daniel E. Leisman discuss their recent paper published in Critical Care Medicine discussing guidance on the development of prediction models for critical care

Don Sin discusses a new tool for clinicians to use to detect potential exacerbations in patients with chronic obstructive pulmonary disorder.

Authors of the MERGE Trial discuss treatment of mild obstructive sleep apnea and the effectiveness of continuous positive airway pressure, or CPAP, in the treatment of patients with mild OSA

Authors from a new case series talk about the development of an algorithm they developed for the diagnosis and treatment of e-cigarette or vaping product use-associated lung injury, or EVALI.

Dr. Marcelo Cypel discusses a trial looking at lung transplantation from Hepatitis C viremic donors.